AT
CLB icon

Arden Trust’s Core Laboratories CLB Stock Holding History

Arden Trust’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-3,133
Closed -$388 – 356
2016
Q2 		$388 Buy
3,133
+299
+11% +$36.1K 0.03% 401
2016
Q1 		$318K Sell
2,834
-704
-20% -$73.1K 0.03% 456
2015
Q4 		$384K Buy
3,538
+1,474
+71% +$169K 0.03% 418
2015
Q3 		$206K Buy
+2,064
New +$224K 0.02% 636

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
EA
Emerald Acquisition Seattle, Washington $51.8B AUM

Arden Trust's CLB Position: Q3 2016 in Review

Arden Trust sold out of Core Laboratories (CLB) in Q3 2016, closing a stake of 3,133 shares — an estimated $388 sold.

Arden Trust first reported a position in CLB in Q3 2015 and held it in 4 quarters. The position peaked at $384K in Q4 2015. 372 funds tracked by Wall St. Rank hold CLB as of Q3 2016.

  • Arden Trust reported no remaining Core Laboratories position as of Q3 2016 after selling out during the quarter.
  • Arden Trust sold 3,133 Core Laboratories shares in Q3 2016, an estimated $388.
  • Arden Trust first reported a position in Core Laboratories in Q3 2015 and held it in 4 quarters.
  • Arden Trust's Core Laboratories position peaked at $384K in Q4 2015.
  • 372 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2016.

Based on Arden Trust's 13F filing for Q3 2016, filed 14 Oct 2016.